Authorization for the purchase of Remdesivir was published in “Diário da República”. It foresees the acquisition of one hundred thousand bottles to treat covid-19 and this year expenses up to 20 million euros.
The purchase decision was approved by the Council of Ministers on October 22 and on that day announced by the Minister of Health, Marta Temido, who said that the Directorate-General for Health would acquire between October and March 2021 more than 100 thousand bottles of antiviral medicine Remdesivir, under the trade name Veklury, for the treatment of patients with covid-19.
At the time, the minister explained that “the acquisition of more than one hundred thousand bottles” will cost about 35 million euros, since each costs 345 euros.
Remdesivir is indicated for the treatment of adult and adolescent patients with pneumonia who need supplemental oxygen and was authorized in the European Union for covid-19, recalled Marta Temido.
According to the resolution of the Council of Ministers now published, the purchase of the medicine is authorized up to a maximum amount of 35,376,645 euros, and the expenses with the expenditure cannot exceed 19,458,000 euros in 2020 and 15,918,645 euros in the next year.
The resolution recalls that the European Commission signed on October 7, on behalf of all the countries of the European Union, “a framework contract for joint acquisitions” with the pharmaceutical group Gilead Sciences for the supply of Remdesivir treatment doses, the first medicine authorized in the Union for covid-19.
And it is also stated that one of the conditions of the referred framework contract “is the need for each participating country to establish and sign a specific contract that will allow its execution in the national territory”, which is why the Government’s resolution appears.
The resolution stipulates that the financial burden is met by adequate funds entered and to be entered in the budget of the Directorate-General for Health.
These were the details of the news Green light for the purchase of antiviral Remdesivir to treat covid... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at time24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.